Skip to main content

HCA Healthcare, Inc.

corporate_fare Company Profile

HCA Healthcare, Inc.

HCA·NYSE·Trade & Services·CIK 0000860730

HCA Healthcare, Inc. is a leading healthcare services company in the United States. As of December 31, 2025, the company operated 190 hospitals, which included 179 general acute care hospitals, seven behavioral hospitals, and four rehabilitation hospitals. Additionally, HCA Healthcare operated 121 freestanding ambulatory surgery centers and 31 freestanding endoscopy centers. Its facilities are located across 19 states and England. The company's primary goal is to deliver a wide range of quality healthcare services as cost-effectively as possible. Its general acute care hospitals offer comprehensive services for medical specialties such as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics, and obstetrics, alongside diagnostic and emergency services. Outpatient and supporting healthcare services are provided through its general acute care hospitals, ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, physician practices, diagnostic centers, home health agencies, hospices, and rehabilitation facilities, among others. The behavioral hospitals provide a full spectrum of mental health care services in inpatient, partial hospitalization, and outpatient settings. HCA Healthcare, Inc. was incorporated in Delaware in October 2010, building on operations that began in 1968 through its predecessors. Its common stock is traded on the New York Stock Exchange under the symbol "HCA."

HCA Healthcare, Inc. (NYSE:HCA) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 25 items for HCA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-15, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 8/10, with 9 rated 8 or above. Recent SEC coverage for HCA spans 10-Q, 8-K, DEF 14A.

Recent high-impact activity:

  • HCA Healthcare Completes Acquisition of The College of Health Care Professions
  • HCA Q2 Revenue Tops $20.2B, but Uncompensated Care Surges and Cash Flow Drops
  • HCA Narrows Revenue View to $77B-$79.5B, Trims EPS Outlook
  • HCA Q2 Profit Rises to $1.7B, Revenue Hits $20.2B; Full-Year Revenue Guidance Set at $77B-$79.5B
  • HCA Healthcare Delivers Q2 2026 Results, Declares Dividend, and Updates Guidance

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$75.6B
Net Income
$6.78B
Diluted EPS
$28.33
Op. Cash Flow
$12.64B
Free Cash Flow
$7.69B
Cash & Equivalents
$1.04B
Total Debt
$46.49B
Debt / Equity
-7.71×
Net Margin
9.0%
Shares Outstanding
224.61M sh
Source: 10-K · filed 2026-02-10 · accession 0001193125-26-044769

Short Interest & Short Volume

4.52 days to cover

FINRA reported short interest of 6,479,985 shares in HCA as of the September 15, 2026 settlement, a 5.6% increase from the prior period — about 4.5 days to cover at its recent average daily volume. On October 2, 2026, 70.5% of HCA volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)6,479,985 shares as of September 15, 2026
Change vs prior period▲ 5.6%
Days to cover4.52 at avg daily volume of 1,433,168
Daily short volume (FINRA facilities)70.5% of 265,221 shares on October 2, 2026
5-day average short volume56.7%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for HCA, detected from its recent SEC filings · based on capital-structure filings through 2026-04-27.

1 recent capital raise1 shelf registration

⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with H →
$426.69
52-week range · as of 2026-07-28 $331.61 – $556.52
Market cap
$92.38B
Volume
929.8K (0.7× avg)
3-mo avg 1.4M
Live data · 2026-10-03 07:56 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed HCA - Latest Insights

HCA
Sep 15, 2026, 8:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $423.00
Real-time Price: $426.69 info
Change: +$3.69 (+0.87%) info
Market Cap: $92.379B info
HCA
Jul 28, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $417.50
Real-time Price: $426.69 info
Change: +$9.19 (+2%) info
Market Cap: $92.379B info
HCA
Jul 24, 2026, 8:13 AM EDT
Source: dpa-AFX
Importance Score:
7
Price at Filing: $379.20
Real-time Price: $426.69 info
Change: +$47.49 (+13%) info
Market Cap: $92.379B info
HCA
Jul 24, 2026, 7:57 AM EDT
Source: dpa-AFX
Importance Score:
8
Price at Filing: $369.00
Real-time Price: $426.69 info
Change: +$57.69 (+16%) info
Market Cap: $92.379B info
HCA
Jul 24, 2026, 7:45 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $369.00
Real-time Price: $426.69 info
Change: +$57.69 (+16%) info
Market Cap: $92.379B info
HCA
Jul 24, 2026, 7:43 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $369.00
Real-time Price: $426.69 info
Change: +$57.69 (+16%) info
Market Cap: $92.379B info
HCA
Jul 20, 2026, 7:21 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $385.55
Real-time Price: $426.69 info
Change: +$41.14 (+11%) info
Market Cap: $92.379B info
HCA
Jul 19, 2026, 3:14 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $371.19
Real-time Price: $426.69 info
Change: +$55.50 (+15%) info
Market Cap: $92.379B info
HCA
Jul 14, 2026, 8:31 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $354.00
Real-time Price: $426.69 info
Change: +$72.69 (+21%) info
Market Cap: $92.379B info
HCA
Jul 14, 2026, 7:40 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $368.00
Real-time Price: $426.69 info
Change: +$58.69 (+16%) info
Market Cap: $92.379B info
HCA
Jul 14, 2026, 7:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $392.00
Real-time Price: $426.69 info
Change: +$34.69 (+9%) info
Market Cap: $92.379B info
HCA
Jun 18, 2026, 9:12 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $395.00
Real-time Price: $426.69 info
Change: +$31.69 (+8%) info
Market Cap: $92.379B info
HCA
May 27, 2026, 4:30 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $392.15
Real-time Price: $426.69 info
Change: +$34.54 (+9%) info
Market Cap: $92.379B info
HCA
Apr 28, 2026, 6:23 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $448.70
Real-time Price: $426.69 info
Change: -$22.01 (-5%) info
Market Cap: $92.379B info
HCA
Apr 27, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $444.01
Real-time Price: $426.69 info
Change: -$17.32 (-4%) info
Market Cap: $92.379B info
HCA
Apr 27, 2026, 4:41 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $448.80
Real-time Price: $426.69 info
Change: -$22.11 (-5%) info
Market Cap: $92.379B info
HCA
Apr 27, 2026, 8:34 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $434.70
Real-time Price: $426.69 info
Change: -$8.01 (-2%) info
Market Cap: $92.379B info
HCA
Apr 24, 2026, 7:13 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $449.99
Real-time Price: $426.69 info
Change: -$23.30 (-5%) info
Market Cap: $92.379B info
HCA
Apr 24, 2026, 7:11 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $437.00
Real-time Price: $426.69 info
Change: -$10.31 (-2%) info
Market Cap: $92.379B info
HCA
Mar 13, 2026, 4:10 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $532.97
Real-time Price: $426.69 info
Change: -$106.28 (-20%) info
Market Cap: $92.379B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets